美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
EVEX	083376	002	ANDA	ESTROGENS, ESTERIFIED	TABLET;ORAL	1.25MG	No	No	1977/09/28	Approved Prior to Jan 1, 1982	ROCHE PALO	Discontinued
EVEX	084215	001	ANDA	ESTROGENS, ESTERIFIED	TABLET;ORAL	0.625MG	No	No	1977/09/28	Approved Prior to Jan 1, 1982	ROCHE PALO	Discontinued
REVEX	020459	001	NDA	NALMEFENE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1995/04/17	1995/04/17	HIKMA	Discontinued
REVEX	020459	002	NDA	NALMEFENE HYDROCHLORIDE	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	EQ 2MG BASE/2ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1995/04/17	1995/04/17	HIKMA	Discontinued